The Codes, They Are A-Changin’
What laboratories should be doing now to prepare for the conversions to ICD-10 and X12 5010.
Read MorePosted by Clinical Lab Products | Sep 2, 2009 | Cancer, Miscellaneous |
What laboratories should be doing now to prepare for the conversions to ICD-10 and X12 5010.
Read MorePosted by Clinical Lab Products | Sep 1, 2009 | Cancer, Miscellaneous |
Point-of-care testing aims to improve health care with quick turnaround times.
Read MorePosted by Clinical Lab Products | Aug 14, 2009 | Cancer, Colorectal, Miscellaneous |
Epigenomics AG, a cancer molecular diagnostics company, today announced that it signed a non-exclusive licensing agreement for its proprietary DNA methylation biomarker Septin 9 (mSEPT9) with Salt Lake City, Utah. based ARUP Laboratories Inc.
Read MorePosted by Clinical Lab Products | Aug 14, 2009 | Miscellaneous |
Beckman Coulter Inc announces the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities.
Read MorePosted by Clinical Lab Products | Aug 6, 2009 | Miscellaneous |
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.
Read More